Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer

被引:0
|
作者
Xin, Shuyue [1 ]
Wen, Shuang [2 ]
He, Peipei [1 ]
Zhao, Yulong [1 ]
Zhao, Hui [1 ]
机构
[1] Dalian Med Univ, Dept Hlth Examinat Ctr, Affiliated Hosp 2, Dalian, Peoples R China
[2] Friendship Hosp Dalian, Dept Pathol, Dalian, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
tertiary lymphoid structures (TLS); non-small cell lung cancer (NSCLC); prognosis; tumor immune microenvironment (TIME); nomogram; RELEVANCE; CD47;
D O I
10.3389/fimmu.2024.1423775
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Tertiary lymphoid structures (TLS), ordered structure of tumor-infiltrating immune cells in tumor immune microenvironment (TIME), play an important role in the development and anti-tumor immunity of various cancers, including liver, colon, and gastric cancers. Previous studies have demonstrated that the presence of TLS in intra-tumoral (IT), invasive margin (IM), and peri-tumoral (PT) regions of the tumors at various maturity statuses. However, the density of TLS in different regions of non-small cell lung cancer (NSCLC) has not been extensively studied.Methods TLS and tumor-infiltrating immune cells were assessed using immunohistochemistry (IHC) staining in 82 NSCLC patients. Tumor samples were divided into three subregions as IT, IM and PT regions, and TLS were identified as early/primary TLS (E-TLS) or secondary/follicular TLS (F-TLS). The distribution of TLS in different maturity statuses, along with their correlation with clinicopathological characteristics and prognostic value, was assessed. Nomograms were used to predict the probability of 1-, 3-, and 5-year overall survival (OS) in patients with NSCLC.Results The density of TLS and proportion of F-TLS in the IT region (90.2%, 0.45/mm2, and 61.0%, respectively) were significantly higher than those in the IM region (72.0%, 0.18/mm2, and 39.0%, respectively) and PT region (67.1%, 0.16/mm2, and 40.2%, respectively). A lower density of TLS, especially E-TLS in the IM region, was correlated with better prognosis in NSCLC patients. CD20+ B cells, CD3+ T cells, CD8+ cytotoxic T cells, and CD68+ macrophages were significantly overexpressed in the IM region. CD20+ B cells and CD3+ T cells in the IM region were significantly correlated with the density of E-TLS, while no statistically significant correlation was found with F-TLS. The E-TLS density in the IM region and TNM stage were independent prognostic factors for NSCLC patients. The nomogram showed good prognostic ability.Conclusions A higher density of E-TLS in the IM region was associated with a worse prognosis in NSCLC patients, potentially due to the inhibition of TLS maturation caused by the increased density of suppressive immune cells at the tumor invasion front.
引用
收藏
页数:15
相关论文
共 50 条
  • [32] Surgical treatment and prognosis of octogenarians with non-small cell lung cancer
    Jing Zhang
    Zhi-Qiang Xue
    Xiang-Yang Chu
    Yun-Xi Wang
    Jia-Hua Zhao
    Chi Xu
    Li-Guo Yin
    [J]. Asian Pacific Journal of Tropical Medicine, 2012, (06) : 465 - 468
  • [33] Prognosis of non-small cell lung cancer patients with brain metastasis
    Ohhara, Yoshihito
    Isobe, Hiroshi
    Sato, Toshitaka
    Ito, Kenichiro
    Fuke, Satoshi
    Kojima, Tetsuya
    Saito, Hiroshi
    Nishiura, Yoichi
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 106 - 106
  • [34] Imprinted Genes Predict Non-Small Cell Lung Cancer Prognosis
    Zhou, J.
    Cheng, T.
    Li, X.
    Wang, X.
    Si, H.
    Zhao, P.
    Yung, R.
    Shen, R.
    Yu, H.
    Lu, S.
    Huang, W.
    Zhou, N.
    Bai, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S705 - S705
  • [35] Utilizing immune cells for prognosis in non-small cell lung cancer
    Frafjord, Astri
    Meas-Yedid, Vannary
    Aamodt, Henrik
    Beraki, Kahsai
    Lomo, Jon
    Loberg, Else Marit
    Hammarstrom, Clara
    Oynebraten, Inger
    Corthay, Alexandre
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 310 - 310
  • [36] A novel immunogenomic classification for prognosis in non-small cell lung cancer
    Tang, Shu
    Xu, Liqing
    Wu, Zhanshen
    Wen, Qiang
    Li, Hui
    Li, Na
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10951 - 10964
  • [37] Prognosis in Patients with Non-Small Cell Lung Cancer and Satellite Tumors
    Kocaturk, C. I.
    Gunluoglu, M. Z.
    Cansever, L.
    Dincer, I. S.
    Bedirhan, M. A.
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2011, 59 (06): : 360 - 363
  • [38] Molecular gene signature and prognosis of non-small cell lung cancer
    Huang, Poyin
    Cheng, Chiou-Ling
    Chang, Ya-Hsuan
    Liu, Chia-Hsin
    Hsu, Yi-Chiung
    Chen, Jin-Shing
    Chang, Gee-Chen
    Ho, Bing-Ching
    Su, Kang-Yi
    Chen, Hsuan-Yu
    Yu, Sung-Liang
    [J]. ONCOTARGET, 2016, 7 (32) : 51898 - 51907
  • [39] Prognosis for non-small cell lung cancer patients with brain metastases
    Kim, Junghyun
    Lee, Sang-Min
    Yim, Jae-Jun
    Yoo, Chul Gyu
    Kim, Young Whan
    Han, Sung Koo
    Yang, Seok-Chul
    [J]. THORACIC CANCER, 2013, 4 (02) : 167 - 173
  • [40] A novel immunogenomic classification for prognosis in non-small cell lung cancer
    Shu Tang
    Liqing Xu
    Zhanshen Wu
    Qiang Wen
    Hui Li
    Na Li
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10951 - 10964